共 14 条
[1]
The role of glucagon‐like peptide‐1 impairment in obesity and potential therapeutic implications[J] S. Madsbad Diabetes Obes Metab 2014,
[2]
GLP ‐1 analogue prevents NAFLD in ApoE KO mice with diet and Acrp30 knockdown by inhibiting c‐ JNK[J] Lili Zhang;Mengliu Yang;Hong Ren;Huaidong Hu;Guenther Boden;Ling Li;Gangyi Yang Liver Int 2013,
[3]
Novel Insights Into the Regulation of Postprandial Lipemia by Glucagon-Like Peptides: Significance for Diabetes[J] Watts; Gerald F;Chan; Dick C Diabetes 2013,
[4]
Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta‐analysis of the LEAD program[J] M. J. Armstrong;D. D. Houlihan;I. A. Rowe;W. H. O. Clausen;B. Elbr?nd;S. C. L. Gough;J. W. Tomlinson;P. N. Newsome Aliment Pharmacol Ther 2012,
[5]
Effect of the once-daily human GLP-1 analogue liraglutide on appetite; energy intake; energy expenditure and gastric emptying in type 2 diabetes[J] Michael Horowitz;Anne Flint;Karen L. Jones;Charlotte Hindsberger;Mads F. Rasmussen;Christoph Kapitza;Selena Doran;Thomas Jax;Milan Zdravkovic;Ian M. Chapman Diabetes Research and Clinical Practice 2012,
[6]
Direct effect of GLP-1 infusion on endogenous glucose production in humans[J] M. Seghieri;E. Rebelos;A. Gastaldelli;B. D. Astiarraga;A. Casolaro;E. Barsotti;A. Pocai;M. Nauck;E. Muscelli;E. Ferrannini Diabetologia 2012,
[7]
Liraglutide: short‐lived effect on gastric emptying—long lasting effects on body weight[J] J.Jelsing;N.Vrang;G.Hansen;K.Raun;M.Tang‐Christensen;L.Bjerre Knudsen Diabetes; Obesity and Metabolism 2012,
[8]
Incretin-Based Therapies for Type 2 Diabetes Mellitus: Properties; Functions; and Clinical Implications[J] Michael A. Nauck The American Journal of Medicine 2011,
[9]
GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in Mice[J] Noyan-Ashraf; Mohammad Hossein;Momen; M Abdul;Ban; Kiwon;Sadi; Al-Muktafi;Zhou; Yu-Qing;Riazi; Ali M;Baggio; Laurie L;Henkelman; R Mark;Husain; Mansoor;Drucker; Daniel J Diabetes 2009,
[10]
Beneficial effects of once‐daily liraglutide; a human glucagon‐like peptide‐1 analogue; on cardiovascular risk biomarkers in patients with Type?2 diabetes[J] Diabetic Medicine 2008,